| Financial Year |
March 31 2023 |
| Monetary Funds |
5,297,999,204.12 |
| Held-for-trading Financial Assets |
254,840,893.06 |
| Notes Receivable |
95,380,761.00 |
| Accounts Receivable |
1,828,774,486.43 |
| Advances to Suppliers |
448,692,190.85 |
| Other Receivables |
160,781,320.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,417,036,198.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,257,563.27 |
| Other Current Assets |
110,387,096.97 |
| Total Current Assets |
10,722,465,549.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,050,790.70 |
| Long-term Equity Investment |
1,209,323,392.33 |
| Investment Properties |
311,365,691.53 |
| Fixed Assetes |
2,615,409,533.41 |
| Under-construction Projects |
1,601,186,923.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,379,956,948.07 |
| R&D expenses |
1,045,839,485.58 |
| Goodwill |
3,330,976,810.89 |
| Long-Term Deferred and Prepaid Expenses |
223,610,580.51 |
| Deferred Income Tax Assets |
129,493,175.92 |
| Other Non-Current Assets |
422,598,086.82 |
| Sub-Total of Non-Current Assets |
13,837,436,967.46 |
| Total Assets |
24,559,902,516.86 |
| Short-Term Loans |
311,678,033.93 |
| Trading Financial liabilities |
1,500,301.55 |
| Notes Payable |
139,177,968.16 |
| Accounts Payable |
1,194,618,684.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
61,787,123.31 |
| Taxes Payable |
256,614,531.71 |
| Interest Payable |
-- |
| Dividend Payable |
3,353,503.56 |
| Other payables |
427,013,823.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,480,873,055.19 |
| Other Current Liabilities |
77,370,298.57 |
| Sub-Total of Current Liabilities |
4,270,711,558.07 |
| Long-term Loans |
1,167,791,298.83 |
| Bonds Payable |
1,513,534,004.81 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
211,807,574.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,206,837,426.19 |
| Total Liabilities |
7,477,548,984.26 |
| Paid-In Capital(Or Share Stock) |
1,880,609,906.00 |
| Capital Surplus |
3,281,819,976.72 |
| Surplus Reserve |
664,046,161.45 |
| LESS:Treasury Stock |
355,820,438.37 |
| Undistributed Profits |
10,187,223,021.04 |
| Minority Stockholder's Interest |
1,258,717,064.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,823,636,468.24 |
| Owner's Equity（Stockholder's Equity） |
17,082,353,532.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,559,902,516.86 |
